Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mouritzen, U
Right arrow Articles by Christiansen, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mouritzen, U
Right arrow Articles by Christiansen, C
Annals of the Rheumatic Diseases 2003;62:332-336
© 2003 by BMJ Publishing Group & European League Against Rheumatism


EXTENDED REPORT

Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index

U Mouritzen 1, S Christgau 1,2, H-J Lehmann 1, L B Tankó , C Christiansen

1 Centre for Clinical and Basic Research A/S, Ballerup, Denmark
2 Nordic Bioscience A/S, Herlev, Denmark

Correspondence to:
Correspondence to:
Dr U Mouritzen, Centre for Clinical and Basic Research A/S, Ballerup Byvej 222, DK-2750 Ballerup, Denmark;
ig{at}ccbr.dk

Background: Cartilage normally has a slow turnover but in arthritis increased metabolism results in degradation of the tissue.

Objective: To assess cartilage turnover in a sample of the general population by an assay measuring cartilage derived urinary collagen type II (CTX-II) C-telopeptide degradation products.

Methods: CTX-II concentrations were measured in urine samples from 615 healthy men and women aged 20–87 years, and the influence of age, sex, menopause, hormone replacement therapy (HRT), and body mass index (BMI) was assessed.

Results: CTX-II concentrations showed age dependent variations, with notable differences between men and women. Mean (SD) CTX-II concentration in postmenopausal women (220 (118) ng/mmol, n=25) was significantly higher than in an age matched group of premenopausal women (112 (79) ng/mmol, n=26, p<0.001). CTX-II concentration in women using HRT (118 (57) ng/mmol, n=50) was significantly lower than in an age and BMI matched group of women not receiving HRT (215 (99) ng/mmol, n=50, p<0.001). In subjects with a BMI >=25 kg/m2, CTX-II concentrations were significantly higher than in those with a BMI <25 kg/m2 (185 (114) v 148 (91) ng/mmol, p<0.001).

Conclusions: Cartilage turnover, as assessed by measuring urinary degradation products of CTX-II varies considerably with age, and significant differences between CTX-II levels in men and women as well as in pre- and postmenopausal women are found. Further studies are required to validate the marker for assessing cartilage degradation in arthritis.


Keywords: cartilage; collagen; biological markers; osteoarthritis

Abbreviations: BMI, body mass index; CTX-II, collagen type II; ELISA, enzyme linked immunosorbent assay; HRT, hormone replacement therapy; OA, osteoarthritis; RA, rheumatoid arthritis




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
M. A. KARSDAL, B. C. SONDERGAARD, M. ARNOLD, and C. CHRISTIANSEN
Calcitonin Affects Both Bone and Cartilage: A Dual Action Treatment for Osteoarthritis?
Ann. N.Y. Acad. Sci., November 1, 2007; 1117(1): 181 - 195.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
P. Richette, M.-F. Dumontier, K. Tahiri, M. Widerak, A. Torre, M. Benallaloua, F. Rannou, M.-T. Corvol, and J.-F. Savouret
Oestrogens inhibit interleukin 1{beta}-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-{kappa}B impairment
Ann Rheum Dis, March 1, 2007; 66(3): 345 - 350.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
P Garnero, N Charni, F Juillet, T Conrozier, and E Vignon
Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis
Ann Rheum Dis, December 1, 2006; 65(12): 1639 - 1644.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S A Mazzuca, K D Brandt, D R Eyre, B P Katz, J Askew, and K A Lane
Urinary levels of type II collagen C-telopeptide crosslink are unrelated to joint space narrowing in patients with knee osteoarthritis
Ann Rheum Dis, August 1, 2006; 65(8): 1055 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
I Meulenbelt, M Kloppenburg, H M Kroon, J J Houwing-Duistermaat, P Garnero, M-P Hellio Le Graverand, J DeGroot, and P E Slagboom
Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study
Ann Rheum Dis, March 1, 2006; 65(3): 360 - 365.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
K. Mithoefer, R. J. Williams III, R. F. Warren, H. G. Potter, C. R. Spock, E. C. Jones, T. L. Wickiewicz, and R. G. Marx
The Microfracture Technique for the Treatment of Articular Cartilage Lesions in the Knee. A Prospective Cohort Study
J. Bone Joint Surg. Am., September 1, 2005; 87(9): 1911 - 1920.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
J I Kuiper, J H A M Verbeek, V Everts, J P Straub, and M H W Frings-Dresen
Serum markers of collagen metabolism: construction workers compared to sedentary workers
Occup. Environ. Med., June 1, 2005; 62(6): 363 - 367.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Ding, F Cicuttini, F Scott, H Cooley, and G Jones
Association between age and knee structural change: a cross sectional MRI based study
Ann Rheum Dis, April 1, 2005; 64(4): 549 - 555.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & European League Against Rheumatism